Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Expression of serotonin receptor mRNAs in blood vessels
- C. Ullmer, K. Schmuck, H. Kalkman, H. Lübbert
- BiologyFEBS letters
- 21 August 1995
Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and…
- D. Hoyer, G. Engel, H. Kalkman
- Biology, ChemistryEuropean journal of pharmacology
- 26 November 1985
Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects
- R. Rupprecht, G. Rammes, K. Kucher
- Psychology, BiologyScience
- 24 July 2009
Keeping Calm Benzodiazepines are the most prescribed anxiolytics and are used by a broad population. However, benzodiazepines can cause unwanted side effects, including sedation, development of…
A review of the evidence for the canonical Wnt pathway in autism spectrum disorders
- H. Kalkman
- BiologyMolecular Autism
- 19 October 2012
TLDR
Activation of Meningeal 5‐HT2B Receptors: An Early Step in the Generation of Migraine Headache?
- K. Schmuck, C. Ullmer, H. Kalkman, A. Probst, H. Lübbert
- Biology, MedicineThe European journal of neuroscience
- 1 May 1996
TLDR
Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.
- D. Hoyer, G. Engel, H. Kalkman
- Biology, ChemistryEuropean journal of pharmacology
- 26 November 1985
Cloning and functional characterization of the rat stomach fundus serotonin receptor.
- M. Foguet, D. Hoyer, H. Lübbert
- BiologyThe EMBO journal
- 1 September 1992
TLDR
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders
- H. Kalkman, D. Feuerbach
- Psychology, MedicineCellular and Molecular Life Sciences
- 15 March 2016
TLDR
alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
- H. Kalkman, E. Loetscher
- Psychology, MedicineEuropean journal of pharmacology
- 21 February 2003
(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity.
- J. Nozulak, H. Kalkman, P. Floersheim, D. Hoyer, P. Schoeffter, H. Buerki
- Chemistry, BiologyJournal of medicinal chemistry
- 6 January 1995
TLDR
...
...